Fabrice Jardin Selected Research

Drug Therapy (Chemotherapy)

2/2022	Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
1/2022	Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.
4/2021	Angiogenesis imaging study using interim [18F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence.
12/2019	How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
2/2019	Benefit of cetuximab addition to a platinum-fluorouracil-based chemotherapy according to KRAS-LCS6 variant in an unselected population of recurrent and/or metastatic head and neck cancers.
11/2015	MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study.
11/2015	Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial.
5/2015	¹⁸F-FDG-PET/CT Imaging in Patients with Febrile Neutropenia and Haematological Malignancies.
12/2014	Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.
7/2014	Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabrice Jardin Research Topics

Disease

44	Neoplasms (Cancer) 06/2022 - 01/2005
30	Lymphoma (Lymphomas) 01/2022 - 06/2002
27	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2022 - 05/2011
21	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 06/2005
11	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 12/2007
9	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 09/2012
8	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 03/2010
6	Infections 07/2022 - 12/2009
6	Residual Neoplasm 03/2021 - 01/2016
4	Neutropenia 04/2022 - 11/2005
3	Thrombocytopenia (Thrombopenia) 04/2022 - 12/2009
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2022 - 01/2005
3	Leukemia 12/2019 - 11/2015
3	Hematologic Neoplasms (Hematological Malignancy) 10/2017 - 01/2005
2	Anemia 04/2022 - 12/2009
2	Splenomegaly 04/2022 - 06/2005
2	Pain (Aches) 02/2022 - 12/2009
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 11/2005
2	Adenocarcinoma of Lung 01/2021 - 01/2018
2	Inflammation (Inflammations) 01/2020 - 03/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 05/2013
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 03/2013
2	Carcinogenesis 01/2019 - 01/2017
2	Fever (Fevers) 08/2018 - 06/2005
2	Breast Neoplasms (Breast Cancer) 11/2016 - 01/2014
2	Heart Failure 11/2015 - 04/2015
2	Febrile Neutropenia 05/2015 - 04/2013
2	Sarcopenia 07/2014 - 04/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2022
1	Hairy Cell Leukemia 04/2022
1	Leukopenia 04/2022
1	Fatigue 02/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2021
1	COVID-19 12/2021
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021

Drug/Important Bio-Agent (IBA)

25	Rituximab (Mabthera)FDA Link 10/2021 - 06/2005
15	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 07/2015
10	Cell-Free Nucleic AcidsIBA 06/2022 - 07/2015
9	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2013
6	Biological ProductsIBA 04/2022 - 03/2008
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2012
6	Prednisone (Sone)FDA LinkGeneric 12/2019 - 05/2011
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 05/2011
6	Vincristine (Oncovin)FDA LinkGeneric 12/2019 - 05/2011
6	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 05/2011
5	Exportin 1 ProteinIBA 09/2020 - 01/2016
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 04/2015
4	Monoclonal AntibodiesIBA 01/2022 - 03/2008
3	Circulating Tumor DNAIBA 06/2022 - 01/2021
3	NucleotidesIBA 01/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2017
3	Cyclin D1IBA 01/2019 - 08/2017
3	Histone Deacetylase InhibitorsIBA 01/2019 - 04/2015
2	ParaffinIBA 01/2022 - 01/2018
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 11/2021 - 01/2021
2	Lenalidomide (CC 5013)FDA Link 10/2021 - 09/2018
2	Complement System Proteins (Complement)IBA 03/2021 - 06/2016
2	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 09/2007
2	Bendamustine Hydrochloride FDA Link 01/2021 - 01/2019
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 01/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 07/2015
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2019 - 03/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 03/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 09/2007
2	ChromatinIBA 01/2019 - 01/2016
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2017 - 09/2013
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2005
2	AnthracyclinesIBA 11/2015 - 01/2012
2	pegfilgrastim (Neulasta)FDA Link 04/2013 - 12/2009
2	Imatinib Mesylate (Gleevec)FDA Link 02/2013 - 09/2005
2	AntibodiesIBA 09/2011 - 01/2011
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 09/2007 - 06/2002
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 02/2022
1	InterferonsIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	VaccinesIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021
1	TropomyosinIBA 11/2021
1	Arginine (L-Arginine)FDA Link 04/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 04/2021
1	FluorineIBA 04/2021
1	Gemcitabine FDA Link 01/2021
1	SOXC Transcription FactorsIBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	pembrolizumabIBA 01/2021

Therapy/Procedure

23	Therapeutics 02/2022 - 01/2005
21	Drug Therapy (Chemotherapy) 02/2022 - 11/2005
7	Ligation 01/2022 - 04/2015
6	Stem Cell Transplantation 01/2022 - 01/2013
4	Transplantation 12/2017 - 01/2013
2	Combination Drug Therapy (Combination Chemotherapy) 06/2019 - 09/2012
2	Precision Medicine 10/2017 - 05/2015
2	Hematopoietic Stem Cell Transplantation 11/2015 - 09/2007
1	Vascular Access Devices (Arterial Line) 07/2022
1	Catheters 07/2022
1	Medical Day Care (Partial Hospitalization) 12/2021
1	Investigational Therapies (Experimental Therapy) 10/2021